Ni, Yong,Parikh, Bhavnish,Yeleswaram, Krishnaswamy,Erickson-Viitanen, Susan,Williams, William V.
申请号：
AU2013344780
公开号：
AU2013344780B2
申请日:
2013.11.14
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
